Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: Specific host response and responses intermediate between Avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options

mBio

Volumn 5, Issue 1, 2014, Pages

  Josset, Laurence ^a   Zeng, Hui ^b   Kelly, Sara M ^a   Tumpey, Terrence M ^b   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLSALICYLIC ACID; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CHLOROQUINE; CYCLOSPORIN A; CYTOKINE; ETANERCEPT; FONTOLIZUMAB; GENISTEIN; ICOSANOID; INFLIXIMAB; JANUS KINASE INHIBITOR; MINOCYCLINE; PHOSPHOTRANSFERASE INHIBITOR; RESVERATROL; RIBAVIRIN; TROGLITAZONE; VIRUS ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CELL CYCLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DRUG APPROVAL; DRUG IDENTIFICATION; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; INFLUENZA A; INFLUENZA A (H3N2); INFLUENZA A (H5N1); INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H7N7 INFECTION; INFLUENZA VIRUS A H7N9; INFLUENZA VIRUS A H7N9 INFECTION; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SEASONAL INFLUENZA; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; VIRUS CELL INTERACTION; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

ANTIVIRAL AGENTS; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; MINOCYCLINE; TRANSCRIPTOME; VIRUS REPLICATION;

EID: 84903362762     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01102-13     Document Type: Article

References (47)

1. WHO. 2013. Number of confirmed human cases of avian influenza A(H7N9) reported to WHO, global alert and response (GAR). WHO, Geneva, Switzerland.
2. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Lu SH, Yang YD, Fang Q, Shen YZ, Xi XM, Gu Q, Zhou XM, Qu HP, Yan Z, Li FM, Zhao W, Gao ZC, Wang GF, Ruan LX, Wang WH, Ye J, Cao HF, Li XW, Zhang WH, Fang XC, He J, Liang WF, Xie J, Zeng M, Wu XZ, Li J, Xia Q, Jin ZC, Chen Q, Tang C, Zhang ZY, Hou BM, Feng ZX, Sheng JF, Zhong NS, Li LJ. 2013. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N. Engl. J. Med. 368:2277-2285. http:// dx.doi.org/10.1056/NEJMoa1305584.
3. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Zhang Y, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381:1916-1925. http://dx.doi.org/10.1016/S0140-6736(13)60903-4.
4. Belser JA, Bridges CB, Katz JM, Tumpey TM. 2009. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg. Infect. Dis. 15:859-865. http://dx.doi.org/10.3201/ eid1506.090072.
5. Yu H, Cowling BJ, Feng L, Lau EH, Liao Q, Tsang TK, Peng Z, Wu P, Liu F, Fang VJ, Zhang H, Li M, Zeng L, Xu Z, Li Z, Luo H, Li Q, Feng Z, Cao B, Yang W, Wu JT, Wang Y, Leung GM. 2013. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 382:138-145. http://dx.doi.org/10.1016/S0140-6736(13)61207-6.
6. WHO. 2011. Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2010. Wkly. Epidemiol. Rec. 86:161-166. http: //www.who.int/wer/2011/wer8617.pdf.
7. Cowling BJ, Jin L, Lau EH, Liao Q, Wu P, Jiang H, Tsang TK, Zheng J, Fang VJ, Chang Z, Ni MY, Zhang Q, Ip DK, Yu J, Li Y, Wang L, Tu W, Meng L, Wu JT, Luo H, Li Q, Shu Y, Li Z, Feng Z, Yang W, Wang Y, Leung GM, Yu H. 2013. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 382: 129-137. http://dx.doi.org/10.1016/S0140-6736(13)61171-X.
8. Evans ME, Hall KL, Berry SE. 1997. Influenza control in acute care hospitals. Am. J. Infect. Control 25:357-362. http://dx.doi.org/10.1016/ S0196-6553(97)90029-8.
9. ECDC. 2013. Seasonal influenza 2012/2013 in Europe. Risk assessment. ECDC, Stockholm, Sweden.
10. Ip DK, Liao Q, Wu P, Gao Z, Cao B, Feng L, Xu X, Jiang H, Li M, Bao J, Zheng J, Zhang Q, Chang Z, Li Y, Yu J, Liu F, Ni MY, Wu JT, Cowling BJ, Yang W, Leung GM, Yu H. 2013. Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series. BMJ 346:f3693. http:// dx.doi.org/10.1136/bmj.f3693.
11. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. 2013. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 18:20453. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_20453.
12. Liu Q, Lu L, Sun Z, Chen GW, Wen Y, Jiang S. 2013. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes Infect. 15:432-439. http://dx.doi.org/10.1016/j.micinf.2013.04.004.
13. Jonges M, Meijer A, Fouchier RA, Koch G, Li J, Pan JC, Chen H, Shu YL, Koopmans MP. 2013. Guiding outbreak management by the use of influenza A(H7Nx) virus sequence analysis. Euro Surveill. 18:20460. http: //www.eurosurveillance.org/ViewArticle.aspx?ArticleId_20460.
14. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, Sun X, Carney PJ, Villanueva JM, Stevens J, Katz JM, Tumpey TM. 2013. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501:556-559. http://dx.doi.org/10.1038/ nature12391.
15. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D, Chen R, Zheng R, Zhou J, Zhang Y, Hong W, Dong W, Cai Q, Roehrl MH, Huang SS, Kelvin AA, Yao T, Zhou B, Chen X, Leung GM, Poon LL, Webster RG, Webby RJ, Peiris JS, Guan Y, Shu Y. 2013. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341: 183-186. http://dx.doi.org/10.1126/science.1239844.
16. Xiong X, Martin SR, Haire LF, Wharton SA, Daniels RS, Bennett MS, McCauley JW, Collins PJ, Walker PA, Skehel JJ, Gamblin SJ. 2013. Receptor binding by an H7N9 influenza virus from humans. Nature 499: 496-499. http://dx.doi.org/10.1038/nature12372.
17. Tharakaraman K, Jayaraman A, Raman R, Viswanathan K, Stebbins NW, Johnson D, Shriver Z, Sasisekharan V, Sasisekharan R. 2013. Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell 153:1486-1493. http://dx.doi.org/10.1016/j.cell.2013.05.034.
18. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, Zhang X, Yen HL, Shi B, Li T, Guan W, Xu L, Liu Y, Wang S, Tian D, Zhu Z, He J, Huang K, Chen H, Zheng L, Li X, Ping J, Kang B, Xi X, Zha L, Li Y, Zhang Z, Peiris M, Yuan Z. 2013. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 381:2273-2279. http:// dx.doi.org/10.1016/S0140-6736(13)61125-3.
19. Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, Zaki S, Tumpey TM, Katz JM. 2007. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J. Virol. 81:12439-12449. http:// dx.doi.org/10.1128/JVI.01134-07.
20. Sun X, Whittaker GR. 2007. Role of the actin cytoskeleton during influenza virus internalization into polarized epithelial cells. Cell. Microbiol. 9:1672-1682. http://dx.doi.org/10.1111/j.1462-5822.2007.00900.x.
21. Belser JA, Zeng H, Katz JM, Tumpey TM. 2011. Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. J. Infect. Dis. 203: 40-48. http://dx.doi.org/10.1093/infdis/jiq018.
22. Tseng CT, Tseng J, Perrone L, Worthy M, Popov V, Peters CJ. 2005. Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J. Virol. 79: 9470-9479. http://dx.doi.org/10.1128/JVI.79.15.9470-9479.2005.
23. Harcourt JL, Caidi H, Anderson LJ, Haynes LM. 2011. Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection. J. Virol. Methods 174:144-149. http://dx.doi.org/10.1016/ j.jviromet.2011.03.027.
24. Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG. 2013. Cell host response to infection with novel human coronavirusEMCpredicts potential antivirals and important differences with SARS coronavirus. mBio 4(3): e00165-13. http://dx.doi.org/10.1128/mBio.00165-13.
25. Josset L, Textoris J, Loriod B, Ferraris O, Moules V, Lina B, N'Guyen C, Diaz JJ, Rosa-Calatrava M. 2010. Gene expression signature-based screening identifies new broadly effective influenza A antivirals. PLoS One 5:e13169. http://dx.doi.org/10.1371/journal.pone.0013169.
26. Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, Treuting PM, Thomas PG, Dennis EA, Aderem A. 2013. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154:213-227. http://dx.doi.org/10.1016/ j.cell.2013.05.052.
27. Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y. 2013. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153:112-125. http://dx.doi.org/10.1016/j.cell.2013.02.027.
28. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, Takashita E, McBride R, Noda T, Hatta M, Imai H, Zhao D, Kishida N, Shirakura M, de Vries RP, Shichinohe S, Okamatsu M, Tamura T, Tomita Y, Fujimoto N, Goto K, Katsura H, Kawakami E, Ishikawa I, Watanabe S, Ito M, Sakai-Tagawa Y, Sugita Y, Uraki R, Yamaji R, Eisfeld AJ, Zhong G, Fan S, Ping J, Maher EA, Hanson A, Uchida Y, Saito T, Ozawa M, Neumann G, Kida H, Odagiri T, Paulson JC, Hasegawa H, Tashiro M, Kawaoka Y. 2013. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551-555. http://dx.doi.org/10.1038/ nature12392.
29. Liu X, Li T, Zheng Y, Wong K-W, Lu S, Lu H. 2013. Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection. Emerg. Microbes Infect. 2:e27. http://dx.doi.org/10.1038/ emi.2013.30.
30. Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM. 2013. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat. Commun4:2854. http://dx.doi.org/10.1038/ncomms3854.
31. Chan-Tack KM, Murray JS, Birnkrant DB. 2009. Use of ribavirin to treat influenza. N. Engl. J. Med. 361:1713-1714. http://dx.doi.org/10.1056/ NEJMc0905290.
32. Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S. 2005. Neuroprotective and antihuman immunodeficiency virus activity of minocycline. JAMA 293: 2003-2011. http://dx.doi.org/10.1001/jama.293.16.2003.
33. Michaelis M, Kleinschmidt MC, Doerr HW, Cinatl J, Jr. 2007. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J. Antimicrob. Chemother. 60:981-986. http://dx.doi.org/ 10.1093/jac/dkm307.
34. Mishra MK, Basu A. 2008. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J. Neurochem. 105:1582-1595. http:// dx.doi.org/10.1111/j.1471-4159.2008.05238.x.
35. Brun-Buisson C, Richard JC, Mercat A, Thiébaut AC, Brochard L, REVA-SRLFA/H1N1v 2009 Registry Group. 2011. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 183:1200-1206. http:// dx.doi.org/10.1164/rccm.201101-0135OC.
36. Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. 2013. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 23:300-302. http://dx.doi.org/10.1038/cr.2012.165.
37. Chan RW, Yuen KM, Yu WC, Ho CC, Nicholls JM, Peiris JS, Chan MC. 2010. Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS One 5:e8713. http://dx.doi.org/10.1371/ journal.pone.0008713.
38. Josset L, Tisoncik-Go J, Katze MG. 2013. Moving H5N1 studies into the era of systems biology. Virus Res. 178:151-167. http://dx.doi.org/10.1016/ j.virusres.2013.02.011.
39. McDermott JE, Shankaran H, Eisfeld AJ, Belisle SE, Neuman G, Li C, McWeeney S, Sabourin C, Kawaoka Y, Katze MG, Waters KM. 2011. Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems. BMCSyst. Biol. 5:190. http://dx.doi.org/10.1186/1752-0509-5-190.
40. Stewart CE, Torr EE, Mohd Jamili NH, Bosquillon C, Sayers I. 2012. Evaluation of differentiated human bronchial epithelial cell culture systems for asthma research. J. Allergy (Cairo) 2012:943982. http:// dx.doi.org/10.1155/2012/943982.
41. Li C, Bankhead A, III, Eisfeld AJ, Hatta Y, Jeng S, Chang JH, Aicher LD, Proll S, Ellis AL, Law GL, Waters KM, Neumann G, Katze MG, McWeeney S, Kawaoka Y. 2011. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J. Virol. 85:10955-10967. http://dx.doi.org/10.1128/JVI.05792-11.
42. Smyth GK. 2005. Limma: linear models for microarray data, p-397-320. In Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S (ed), Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Springer, New York, NY.
43. Langfelder P, Zhang B, Horvath S. 2008. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24:719-720. http://dx.doi.org/10.1093/bioinformatics/btm563.
44. Venables WN, Ripley BD. 2002. Modern applied statistics with S. Springer, New York, NY.
45. Lamb J. 2007. The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer 7:54-60. http://dx.doi.org/10.1038/nrc2044.
46. Smedley D, Haider S, Ballester B, Holland R, London D, Thorisson G, Kasprzyk A. 2009. BioMart-biological queries made easy. BMC Genomics 10:22. http://dx.doi.org/10.1186/1471-2164-10-S3-S22.
47. Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S, Pico AR, Bader GD, Ideker T. 2012. A travel guide to cytoscape plugins. Nat. Methods 9:1069-1076. http://dx.doi.org/10.1038/nmeth.2212.